Financials
- Market Capitalization 53.7 M
- Employee 21
- Founded 2015
- CEO N/A
- Website www.inmunebio.com
- Headquarter Nevada, United States
- FIGI BBG00LW94L98
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.69
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4250 | BOLD Boundless Bio, Inc. - Common Stock | 2.46 USD | +0.82% | -0.81% | +72.03% | +112.07% | 55.26 M USD | ||
| 4253 | BYSI BeyondSpring, Inc. - Ordinary Shares | 1.33 USD | 0.00% | -18.90% | -17.39% | -41.41% | 54.69 M USD | ||
| 4266 | TIL Instil Bio, Inc. - Common Stock | 7.82 USD | +2.36% | -0.64% | -0.64% | -59.88% | 53.04 M USD | ||
| 4272 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.03 USD | -2.27% | -1.20% | +6.24% | +1136.99% | 52.22 M USD |